Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMOYADT)
| Drug Name | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | 
								AF150(S); SCHEMBL1328277; AF-150S; VGGGBQVTSUMURJ-UHFFFAOYSA-N; AF 150(S); AF-150(S); L007073; 1-methylpiperidine-4-spiro-(2'-methylthiazoline); 2,8-dimethyl-1-thia-3,8-diaza-spiro[4.5]dec-2-ene; 1-Thia-3,8-diazaspiro(4.5)dec-2-ene, 2,8-dimethyl-
								
							 | |||||||||||||||||||
| Indication | 
 | |||||||||||||||||||
| Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
|  Drug Therapeutic Target (DTT) | 
 | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||
| Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||
